Literature DB >> 21359283

Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

Vello Tõugu1, Ann Tiiman, Peep Palumaa.   

Abstract

Amyloid-β peptides (Aβ) are key molecules in Alzheimer's disease (AD) pathology as they form amyloid plaques that are primary hallmarks of AD. There is increasing evidence demonstrating that the biometals zinc(ii) and copper(ii) interact with Aβ peptides and have an influence on their fibrillization and toxicity. Zinc and copper ions are abundantly present in the synaptic areas of the brain, and it is likely that the age-related dyshomeostasis of these biometals is associated with AD pathology. In this review we summarize the knowledge of the interactions of zinc and copper ions with Aβ peptides, their role in Aβ fibrillization and toxicity and provide a critical analysis of the conflicting results in the field. Copper ions entrapped in Aβ fibrils are electrochemically active and can generate ROS in the presence of hydrogen peroxide and reducing agents. This might provide a key for understanding the putative role of copper in Aβ toxicity and AD pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359283     DOI: 10.1039/c0mt00073f

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  54 in total

1.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

2.  Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity.

Authors:  Cristina Sacco; Rachel A Skowronsky; Sunitha Gade; John M Kenney; Anne M Spuches
Journal:  J Biol Inorg Chem       Date:  2012-01-22       Impact factor: 3.358

Review 3.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

Review 4.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

Review 5.  β-Amyloid aggregation and heterogeneous nucleation.

Authors:  Atul K Srivastava; Jay M Pittman; Jonathan Zerweck; Bharat S Venkata; Patrick C Moore; Joseph R Sachleben; Stephen C Meredith
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

6.  Solid-state NMR reveals a comprehensive view of the dynamics of the flexible, disordered N-terminal domain of amyloid-β fibrils.

Authors:  Dan Fai Au; Dmitry Ostrovsky; Riqiang Fu; Liliya Vugmeyster
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

7.  Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide.

Authors:  Zhengjian Lv; Margaret M Condron; David B Teplow; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-11       Impact factor: 4.147

8.  Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules.

Authors:  Liang Xu; Ke Gao; Chunyu Bao; Xicheng Wang
Journal:  J Comput Aided Mol Des       Date:  2012-07-25       Impact factor: 3.686

9.  Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper.

Authors:  Sarah R Sheftic; Jessica M Snell; Suman Jha; Andrei T Alexandrescu
Journal:  Eur Biophys J       Date:  2012-08-21       Impact factor: 1.733

Review 10.  Opportunities in multidimensional trace metal imaging: taking copper-associated disease research to the next level.

Authors:  Stefan Vogt; Martina Ralle
Journal:  Anal Bioanal Chem       Date:  2012-10-19       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.